Compare Glenmark Pharma with Sun Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GLENMARK PHARMA vs SUN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GLENMARK PHARMA SUN PHARMA GLENMARK PHARMA/
SUN PHARMA
 
P/E (TTM) x 12.9 30.9 41.7% View Chart
P/BV x 1.9 4.2 46.7% View Chart
Dividend Yield % 0.5 0.9 55.4%  

Financials

 GLENMARK PHARMA   SUN PHARMA
EQUITY SHARE DATA
    GLENMARK PHARMA
Mar-21
SUN PHARMA
Mar-21
GLENMARK PHARMA/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs573654 87.6%   
Low Rs195339 57.7%   
Sales per share (Unadj.) Rs387.8139.6 277.8%  
Earnings per share (Unadj.) Rs34.49.5 361.0%  
Cash flow per share (Unadj.) Rs50.118.2 275.4%  
Dividends per share (Unadj.) Rs2.507.50 33.3%  
Avg Dividend yield %0.71.5 43.1%  
Book value per share (Unadj.) Rs249.6193.6 128.9%  
Shares outstanding (eoy) m282.172,399.34 11.8%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.03.6 27.9%   
Avg P/E ratio x11.252.1 21.4%  
P/CF ratio (eoy) x7.727.3 28.1%  
Price / Book Value ratio x1.52.6 60.0%  
Dividend payout %7.378.8 9.2%   
Avg Mkt Cap Rs m108,3531,190,430 9.1%   
No. of employees `000NANA-   
Total wages/salary Rs m23,43768,622 34.2%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m109,439334,981 32.7%  
Other income Rs m5028,592 5.8%   
Total revenues Rs m109,941343,573 32.0%   
Gross profit Rs m21,28941,616 51.2%  
Depreciation Rs m4,43620,800 21.3%   
Interest Rs m3,5311,414 249.7%   
Profit before tax Rs m13,82527,994 49.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m4,1245,147 80.1%   
Profit after tax Rs m9,70122,847 42.5%  
Gross profit margin %19.512.4 156.6%  
Effective tax rate %29.818.4 162.2%   
Net profit margin %8.96.8 130.0%  
BALANCE SHEET DATA
Current assets Rs m73,596304,421 24.2%   
Current liabilities Rs m42,010161,456 26.0%   
Net working cap to sales %28.942.7 67.6%  
Current ratio x1.81.9 92.9%  
Inventory Days Days7149 4.4%  
Debtors Days Days8699 86.9%  
Net fixed assets Rs m67,093336,682 19.9%   
Share capital Rs m2822,399 11.8%   
"Free" reserves Rs m70,148462,229 15.2%   
Net worth Rs m70,430464,628 15.2%   
Long term debt Rs m38,8888,981 433.0%   
Total assets Rs m140,689641,103 21.9%  
Interest coverage x4.920.8 23.6%   
Debt to equity ratio x0.60 2,856.4%  
Sales to assets ratio x0.80.5 148.9%   
Return on assets %9.43.8 248.5%  
Return on equity %13.84.9 280.1%  
Return on capital %15.96.2 255.7%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m35,75384,493 42.3%   
Fx outflow Rs m12,02330,334 39.6%   
Net fx Rs m23,72954,159 43.8%   
CASH FLOW
From Operations Rs m11,31261,704 18.3%  
From Investments Rs m-6,7525,362 -125.9%  
From Financial Activity Rs m-4,418-59,805 7.4%  
Net Cashflow Rs m2785,964 4.7%  

Share Holding

Indian Promoters % 46.7 54.5 85.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 35.0 34.0 103.1%  
FIIs % 24.2 13.0 186.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 53.4 45.5 117.2%  
Shareholders   317,383 680,800 46.6%  
Pledged promoter(s) holding % 0.0 4.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GLENMARK PHARMA With:   LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    CADILA HEALTHCARE    



Today's Market

Sensex, Nifty Recover from Day's Low to End Higher; Maruti Suzuki Hits New High Post Q3 Results(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended higher.

Related Views on News

SUN PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 22, 2021 | Updated on Oct 22, 2021

Here's an analysis of the annual report of SUN PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

GLENMARK PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Sep 6, 2021 | Updated on Sep 6, 2021

Here's an analysis of the annual report of GLENMARK PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of GLENMARK PHARMA. Also includes updates on the valuation of GLENMARK PHARMA.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

Sun Pharma Zooms 10% as June Quarter Earnings Beat Estimates (Views On News)

Jul 30, 2021

Here's a rundown on Sun Pharma's June quarter results.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

More Views on News

Most Popular

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look?(Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

Time to Buy Energy Stocks(Fast Profits Daily)

Jan 14, 2022

Energy is a sector that looks set to take off. It's time to get in.

5 Hidden Tata Group Companies to Add to Your Watchlist(Views On News)

Jan 18, 2022

Here's all you need to know about these five Tata group stocks that aren't as popular as the others.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GLENMARK PHARMA SHARE PRICE


Jan 25, 2022 (Close)

TRACK GLENMARK PHARMA

  • Track your investment in GLENMARK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GLENMARK PHARMA

GLENMARK PHARMA - GRANULES INDIA COMPARISON

COMPARE GLENMARK PHARMA WITH

MARKET STATS